Skip to main content

What the FDA labels say about taking them together

Epirubicin and paclitaxel

Epirubicin's FDA label of July 24, 2026 names paclitaxel in its drug interactions section; the paclitaxel labels PlainMeds reads (4) do not name epirubicin. The epirubicin label: “The administration of epirubicin immediately prior to or after paclitaxel increased the systemic exposure of epirubicin, epirubicinol and 7-deoxydoxorubicin aglycone.”

Check it at the source: the epirubicin FDA label on DailyMed (effective July 24, 2026, Pharmacia & Upjohn Company LLC); the paclitaxel FDA label on DailyMed (effective January 21, 2026, Natco Pharma USA LLC).

What does the epirubicin label say about paclitaxel?

Epirubicin label, drug interactions

The administration of epirubicin immediately prior to or after paclitaxel increased the systemic exposure of epirubicin, epirubicinol and 7-deoxydoxorubicin aglycone [see Clinical Pharmacology (12.3) ].

Source: FDA drug label (Ellence), NDA050778 (Pfizer Inc), as published by Pharmacia & Upjohn Company LLC, effective July 24, 2026 (SPL set 0a03c798-a652-4895-b29c-3b521a89ba42), via openFDA; the full label on DailyMed

What does the paclitaxel label say about epirubicin?

Paclitaxel's label (effective January 21, 2026) and its 3 other brand-application labels do not name epirubicin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Paclitaxel), Natco Pharma USA LLC, effective January 21, 2026 (SPL set a1eb16b4-285b-4e81-9c4e-1244d4a52af8), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Epirubicin generic labelers
19Paclitaxel generic labelers
EpirubicinPaclitaxel
Labeled forn/aBreast cancer, Lung cancer
Boxed warningYesYes
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?